Affiliations

• ¹ Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA.
• ² Department of Psychiatry, University of Kentucky, Lexington, KY, USA.
• ³ Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain.
• ⁴ Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain.
• ⁵ Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland.
• ⁶ The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA.
• ⁷ Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
• ⁸ Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.
• ⁹ Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
• ¹⁰ Department of Psychiatry, Tampere University Hospital, Tampere, Finland.
• ¹¹ Department of Psychiatry, Satasairaala, Finland.
• ¹² National Institute of Mental Health, Klecany, Czech Republic.
• ¹³ Department of Psychiatry, Charles University, Third Faculty of Medicine, Prague, Czech Republic.
• ¹⁴ Clinical Pharmacology Unit and Pharmacy Department, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay.
• ¹⁵ Clinical Pharmacology Unit and Outpatient Clinic, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay.
• ¹⁶ Universidad de Oviedo. CIBERSAM. INEUROPA. ISPA-FIMBA, Oviedo, Spain.
• ¹⁷ Hospital Valle del Nalón, Langreo, Spain.
• ¹⁸ Hospital Universitario Central de Asturias, Oviedo, Spain.
• ¹⁹ Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
• ²⁰ Laboratory of Clinical Psychopharmacology, Beijing Anding Hospital, Capital Medical University, Beijing, China.
• ²¹ The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
• ²² Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China.
• ²³ Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
• ²⁴ Substance Abuse Treatment Program, Atlanta VA Medical Center, Decatur, Georgia, USA.
• ²⁵ Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
• ²⁶ Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei, Taiwan.
• ²⁷ Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
• ²⁸ Department of Psychiatry and Brain Disease Research Center, China Medical University Hospital, Taichung, Taiwan.
• ²⁹ Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung, Taiwan.
• ³⁰ Department of Neuropsychiatry, Nowon Eulji Medical Center, Eulji University, School of Medicine, Seoul, Korea.
• ³¹ Department of Psychiatry, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
• ³² Department of Psychiatry, Christian Medical College, Vellore, India.
• ³³ Institute of Mental Health, Jubilee Campus, University of Nottingham, Triumph Road, Nottingham, United Kingdom.
• ³⁴ Instituto Nacional de Neurología y Neurocirugía, México City, México.
• ³⁵ Facultad de Química, Universidad Nacional Autónoma de México (UNAM), México City, México.
• ³⁶ Department of Physiology, Los Andes University Medical School, Mérida, Venezuela.
• ³⁷ Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
• ³⁸ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
• ³⁹ Mental Health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark.
• ⁴⁰ Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France.
• ⁴¹ Department of Physical Medicine and Pharmacology, School of Medicine, Universidad de La Laguna, Canary Islands, Spain.
• ⁴² Hospital Universitario de Canarias, Tenerife, Spain.
• ⁴³ Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, and Instituto Universitario de Neurociencia (IUNE), University of La Laguna, Canary Islands, Spain.
• ⁴⁴ Dutch Clozapine Collaboration Group, Castricum, The Netherlands.
• ⁴⁵ FACT-team in Heerhugowaard, Department of Severe Mental Illness, Mental Health Services North-Holland North, The Netherlands.
• ⁴⁶ Mental Health Team Alkmaar, Mental Health Services Noord-Holland-Noord, Alkmaar, The Netherlands.
• ⁴⁷ Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey.
• ⁴⁸ Addictions Division, Centre for Addiction and Mental Health, Toronto, Canada.
• ⁴⁹ Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
• ⁵⁰ Eastern State Hospital, Lexington, Kentucky, USA.
• ⁵¹ Hazelwood Center, Louisville, Kentucky, USA.
• ⁵² Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead, New York, USA.
• ⁵³ School of Medicine, Keele University, Staffordshire, and Midlands Partnership NHS Foundation Trust, Staffordshire, United Kingdom.
• ⁵⁴ Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
• ⁵⁵ Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
• ⁵⁶ Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Germany.
• ⁵⁷ Grupo de Investigación en Psiquiatría GIPSI, Departamento de Psiquiatría, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia.
• ⁵⁸ Programa Trastornos del Ánimo, Hospital Universitario San Vicente Fundación, Medellín, Colombia.
• ⁵⁹ Department of Pharmacy Practice, University of Montana, Missoula, USA.
• ⁶⁰ Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona, Spain.
• ⁶¹ Department of Psychiatry, Autonomous University of Barcelona, Spain.
• ⁶² Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne, Switzerland.
• ⁶³ Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Switzerland.
• ⁶⁴ School of Pharmaceutical Sciences, University of Geneva, Switzerland.
• ⁶⁵ Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Switzerland.
• ⁶⁶ Department of Psychiatry, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
• ⁶⁷ Center for Drug Sciences, Faculty of Pharmacy, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
• ⁶⁸ Te Korowai Whāriki Central Regional Forensic Service, Capital and Coast District Health Board, Wellington, New Zealand.
• ⁶⁹ Department of Psychological Medicine, University of Otago, Wellington, New Zealand.
• ⁷⁰ Departments of Medical Genetics, Psychiatry, Physiology & Pharmacology, and Community Health Sciences University of Calgary, Alberta, Canada.
• ⁷¹ Faculty of Medicine, University of Montreal, Montreal, Canada.
• ⁷² Department of Pharmacy, Hôpital du Sacré-Cœur de Montréal, Montreal, Canada.
• ⁷³ East London NHS Foundation Trust, London, United Kingdom.
• ⁷⁴ Honorary Clinical Senior Lecturer, Barts and the London School of Medicine, Queen Mary University of London, United Kingdom.
• ⁷⁵ Department of Psychiatry, School of Medicine, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
• ⁷⁶ Department of Psychiatry, Asahi General Hospital, Chiba, Japan.
• ⁷⁷ National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary.
• ⁷⁸ Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
• ⁷⁹ Secretaría de Salud Mental y Adicciones, Ministerio de Salud de la Provincia de Jujuy, San Salvador de Jujuy, Argentina.
• ⁸⁰ Instituto Vilapriño, Center for Studies, Assistance and Research in Neurosciences, Mendoza, Argentina.
• ⁸¹ Department of Psychiatry, LSK Faculty of Medicine, The University of Hong Kong, Hong Kong SAR.
• ⁸² State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR.
• ⁸³ College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
• ⁸⁴ Department of Psychiatry, Hamad Medical Corporation, Doha, Qatar.
• ⁸⁵ NHS, Department of Mental Health, "G. Mazzini" Hospital, Teramo, Italy.
• ⁸⁶ Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
• ⁸⁷ British Columbia Mental Health and Substance Use Research Institute, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
• ⁸⁸ Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria.
• ⁸⁹ Department of Clinical Pharmacology, Astrakhan State Medical University, Astrakhan, Russian Federation.
• ⁹⁰ Department of Psychiatry and Clinical Psychology, Northern State Medical University, Arkhangelsk, Russia.
• ⁹¹ 3rd Department of Psychiatry, Division of Neurosciences, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.
• ⁹² Department of Psychiatry, Medical University of Gdańsk, Gdańsk, Poland.
• ⁹³ Department of Psychiatry, Queens University, Kingston, Canada.
• ⁹⁴ Psychiatry Department, Centro Hospitalar Universitário de S. João, Porto, Portugal.
• ⁹⁵ Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
• ⁹⁶ Sigmund Freud University, Vienna, Austria.
• ⁹⁷ Department of Neurosciences, Jerez University Hospital, Andalusian Health Service, University of Cadiz, Jerez, Spain.
• ⁹⁸ Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocio-IBIS, Sevilla, Spain.
• ⁹⁹ Spanish Network for Research in Mental Health (CIBERSAM), Sevilla, Spain.
• ¹⁰⁰ Department of Psychiatry and Mental Health, University of Cape Town, Valkenberg Hospital, Western Cape, Cape Town, South Africa.
• ¹⁰¹ Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
• ¹⁰² Hospital Central de Maputo, Maputo, Mozambique.
• ¹⁰³ Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
• ¹⁰⁴ Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan.
• ¹⁰⁵ Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
• ¹⁰⁶ Department of Psychiatry, School of Medicine, University of Zagreb, Zagreb, Croatia.
• ¹⁰⁷ Department for Psychiatry and Psychological Medicine, University Hospital Center Zagreb, Croatia.
• ¹⁰⁸ Department of Psychiatry, University Medical Centre Maribor, Maribor, Slovenia.
• ¹⁰⁹ University of Kragujevac, Faculty of Medical Sciences, Department of Psychiatry, Kragujevac, Serbia.
• ¹¹⁰ Group of Resistant Schizophrenia (GER), Schizophrenia Program (Proesq), Federal University of Sao Paulo, SP, Brazil.
• ¹¹¹ Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Sao Paulo, Brazil.
• ¹¹² Department and Institute of Psychiatry and Mental Health, Oporto Faculty of Medicine, Oporto, Portugal.
• ¹¹³ Casa de Salidedo Som Jesus (Psychiatric Hospital), Oporto, Portugal.
• ¹¹⁴ INUBE Biosanitary Research Institute of Extremadura. Extremadura University Hospital and Medical School, Badajoz, Spain.
• ¹¹⁵ Spanish Network for Research in Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
• ¹¹⁶ Cambridge Psychosis Centre, Cambrigeshire and Peterborough NHS Foundation Trust & Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
• ¹¹⁷ Metro South Addiction and Mental Health Service, Brisbane, Australia.
• ¹¹⁸ Queensland Centre for Mental Health Research and School of Clinical Medicine, University of Queensland, Brisbane, Australia.
• ¹¹⁹ Research Unit, Geha Mental Health Center and Molecular Psychiatry Laboratory, Felsenstein Medical Research Center, Tel Aviv, Israel.
• ¹²⁰ Department of Psychiatry Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
• ¹²¹ Psychiatry "A" Department, Hedi Chaker University Hospital, Sfax, Tunisia.
• ¹²² Faculty of Medicine, University of Sfax, Sfax, Tunisia.
• ¹²³ Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
• ¹²⁴ Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
• ¹²⁵ School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
• ¹²⁶ Semel Institute for Neuroscience at UCLA, Los Angeles, CA, USA.
• ¹²⁷ VA Desert Pacific Mental Illness Research, Education, and Clinical Center, Los Angeles, CA, USA.
• ¹²⁸ New York Medical College, Department of Psychiatry and Behavioral Sciences, Valhalla, NY, USA.
• ¹²⁹ Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
• ¹³⁰ Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.